Medical Cannabis Weans Patients Off Opioids, Study Finds
A majority of participants (90.7%) who had been taking opioids and other pain medications were able to stop taking them or reduce their use.
Three Medical Cannabis Companies Fined in Australia For Advertising Products as Cancer and Epilepsy Treatments
Three medical cannabis companies have received fines that total almost $1 million (Australian dollars) from Australia’s drugs regulator.
United States Pharmacopeia Prepares to Add the Cannabis Plant to Its List of Herbal Medicines
The United States Pharmacopeia (USP) is in the process of adding Cannabis sativa to its list of herbal medicines and their properties.
Medical Cannabis Can Improve Sleep and Combat Nightmares in PTSD, Study Finds
The pre-proof study followed the habits of 77 licensed medical cannabis patients and found that shorter time gaps between cannabis use and sleep onset were associated with a lower likelihood of nightmares.
Kentucky Governor Hints That He’ll Legalize Medical Cannabis Via Executive Action
In a press conference on Thursday, September 22, Governor Andy Beshear told journalists that he had received a report from a medical cannabis advisory committee and “there will be some actions forthcoming.”
Cannabis-Pesticide Testing Should Be Standardized Across the US, Say Researchers
Regulators should take a closer look at the health risks presented by a growing cannabis market with no national-level guidance on contamination or pesticide use, a new study argues.
University of Kentucky Launches its Cannabis Research Center
The new UK Cannabis Center will conduct research on the health effects of cannabis, “including its risks and benefits when used to treat certain medical conditions.”
Canadian Government to Publish Review of Cannabis Legalization
The review was set to start last October, three years after Canada legalized recreational cannabis, but the process was delayed for unknown reasons.
Cannabis Hyperemesis Syndrome Cases Have Risen With Cannabis Commercialization, Study Finds
Large increases in CHS emergency department visits were seen shortly following the wider market commercialization in Ontario, which included the opening of more retail stores and the sale of more diverse and potent products.
